Trial Profile
Efficacy and safety of carotuximab in combination with bevacizumab in patients with refractory and metastatic choriocarcinoma: a compassionate use study
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Sep 2016
Price :
$35
*
At a glance
- Drugs Carotuximab (Primary) ; Bevacizumab
- Indications Choriocarcinoma
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 06 Sep 2016 New trial record